ABSTRACT:
Tyrosine and Serine phosphorylation of the common beta chain (β c ) of the granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin (IL)-3 and IL-5 receptors is widely viewed as a general mechanism that provides positive inputs by coupling the receptor to signaling pathways that stimulate several cellular functions. We show here that despite the known action of Tyr577 in β c to recruit Shc-PI3K pathway members, Tyr577 plays, surprisingly, a negative regulatory role in cell function and, that this is mediated, at least in part, through the uncoupling of SHIP from β c . Fetal liver cells from β c /β IL-3 -/-mice expressing human GM-CSF receptor α chain and β c Tyr577Phe mutant showed enhanced colony formation and expansion of progenitor cells in response to GM-CSF. Dissection of these activities revealed that basal survival was increased, as well as cytokine-stimulated proliferation. As expected the recruitment and activation of Shc was abolished, but interestingly, Gab-2 and Akt phosphorylation increased. Significantly, the activation of PI3K was enhanced and prolonged, accompanied by loss of SHIP activity. These results reveal a previously unrecognised negative signalling role for Tyr577 in β c and demonstrate that uncoupling Shc from cytokine receptors enhances PI3K signalling as well as survival and proliferation.
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1;2 Ligand binding results in the assembly of oligomeric α and β c receptor complexes and the initiation of intracellular signalling cascades through the activation of associated tyrosine kinases. 3 For example, JAK2 is critical for tyrosine phosphorylation of the cytoplasmic domain of the β c subunit and the subsequent recruitment of SH2-and PTB-domain proteins. 2 These events are important for the activation of multiple downstream signalling pathways including the PI-3 kinase (PI3K) pathway and the Ras/MAP kinase (MAPK) pathway. In some cases, the recruitment of signalling proteins occurs via the direct binding of SH2 or PTB domains to the cytoplasmic tail of β c, such as for SHP2 (also named PTP1D or SH-PTP2), which binds tyrosine 612 via its SH2 domain 4 and Shc which binds tyrosine 577 via its PTB domain. 5;6 The tyrosine phosphorylation of these, and other, proteins recruited to β c allows the further recruitment of additional SH2-and PTB-domain signalling proteins and promotes the assembly of a network of signalling complexes on the receptor cytoplasmic tail.
GM-CSF (and IL-3) have been shown to regulate cell survival predominantly via the PI3K pathway. 7 Two possible mechanisms for the recruitment of PI3K to β c have been reported. Our previous studies have shown that the phosphorylation of Ser585 of β c in response to cytokine is required for the binding of the phosphor-serine binding, 14-3-3, family of proteins and subsequent recruitment and activation of PI3K. 8 We have
shown that this Ser585 signaling pathway regulates cell survival alone and is not required for cell proliferation. 8;9 In addition, others have shown that Tyr577 of β c binds the PTB-domain of Shc and is important for subsequent recruitment of a Grb2/Gab2/PI3K complex, although its role in mediating cell survival or proliferation has remained unclear. 10 Other studies have shown that Tyr577 together with Tyr612 plays a role in PI3K signalling in response to GM-CSF. 11 While these studies 12 have been important in identifying receptor tyrosines important for initiating positive signalling, it is now clear that receptor tyrosine residues can also promote negative regulation of intracellular signalling. 13 For example, the suppressors of cytokine
For personal use only. on November 12, 2017 . by guest www.bloodjournal.org From signalling (SOCS) family of proteins are important negative regulators of signalling and directly bind phosphotyrosine residues in cytokine receptors via their SH2 domains. 14;14 Another example is the tyrosine phosphatase, SHP2, which is also recruited to cell surface receptors via its SH2 domain and has negative effects on cytokine signalling. 15 In these instances, negative regulation is important in signal termination and is critical in preventing sustained or prolonged receptor activation leading to deregulated cellular responses. While a number of the proteins involved in the negative regulation of cytokine function have been recognized, 13;16 identifying specific receptor tyrosine residues involved in initiating such functions has proved more difficult. In fact, understanding the receptor proximal events in the negative regulation of cytokine function has lagged considerably behind our understanding of how receptors positively activate specific pathways.
One important mechanism by which growth factor-induced PI3K signaling is downregulated is via lipid phosphatases. These include the hematopoietic-restricted SH2-containing inositol 5'-phosphatase, SHIP1 (originally called SHIP), and the more widely expressed SHIP2. SHIP1 and SHIP2 dephosphorylate PIP3 in the 5' position to give PI(3,4)P2 thereby removing docking sites for PH-domain proteins and terminating downstream PI3K signalling. 17 SHIP1 and SHIP2 exert tight control over PI3K signalling ensuring the production of PIP3 is both rapid and transient in response to growth factors and cytokines. 17 Such rapid and transient PI3K activation has been observed following GM-CSF (and IL-3) stimulation and would suggest an important role for the hematopoietic SHIP1 in attenuating cytokine-mediated PI3K signalling. 8;18 In fact, SHIP1 -/-mice demonstrate deregulated PI3K signalling in the hematopoietic compartment with expansion of granulocyte-macrophage progenitors in both the bone marrow and spleen 19;20 which exhibit enhanced sensitivity to a number of cytokines including GM-CSF. 19;21 While these studies demonstrate an important role for SHIP1
in negatively regulating GM-CSF-mediated PI3K signalling, the mechanisms by which this occurs are not known.
We have now identified an important molecular mechanism by which the β c subunit of the GM-CSF/IL-3/IL-5 receptor negatively regulates the PI3K pathway and modulates specific GM-CSF biologic activities. We have developed a model system that allows both the functional and biochemical analysis of GM-CSF activities in primary mouse In addition, the Tyr577 mutant also showed a concomitant loss of activity of the SH2-containing phosphatase, SHIP but with enhanced phosphorylation of the pro-survival residue Ser585 on β c .
MATERIALS AND METHODS

Transduction of fetal liver and murine bone marrow cells
Fetal liver (FL) or bone marrow (BM) cells from mice devoid of both endogenous GM-CSF receptor beta subunits: Antibodies to Gab2 and SHP2 were purchased from Santa Cruz, (Santa Cruz, CA, USA). All antibodies were used according to manufacturer's instructions.
Biological assays
Colony assays were performed as described previously. 29 In all assays control groups with no cytokines (diluent control of PBS) or a cocktail of IL-6 (50 ng/ml), SCF (100 ng/ml) and erythropoietic (Epo) (4U/ml) were included. For delta assays FL cells were transduced and set up in liquid cultures with either GM-CSF at 100 ng/mL or cocktail of SCF (50 ng/mL), IL-6 (100 ng/mL) and G-CSF (10 ng/mL) for up to 10 days. After this time cells were harvested, counted and plated in colony assays. Proliferation assays were conducted as previously described.
30
Immunoprecipitations and immunoblot analysis
Transduced FL or stable CTL-EN cells were factor-deprived for 12 hours, stimulated with 50ng/mL GM-CSF and lysed in either RIPA buffer (50mM Tris-HCl, pH 7.4, 150mM NaCl, 1.0% NP-40, 0.5% deoxycholate, 0.1% SDS) for Western blotting with phospho-specific antibodies, or NP-40 lysis buffer 8 for immunoprecipitations, and processed as previously described. 8 Signals were developed using enhanced chemiluminescence (ECL;Amersham Pharmacia or West Dura from Pierce).
PI 3-Kinase assay
CTL-EN cells expressing GM-CSF receptors were factor deprived and stimulated with GM-CSF at 50 ng/mL for up to 60 minutes. Cells were lysed in NP-40 lysis buffer and tyrosine phosphorylated proteins immunoprecipitated using 4G10 antibody. PI3K
assays were performed as previously described. PtdIns(3,4,5)P 3 5-phosphatase assays were performed as described previously 31 using β c immunoprecipitations from transduced FL cells. Following the reaction, lipids were extracted and analyzed by TLC chromatography. 31 
RESULTS
Transduction of fetal liver, murine bone marrow and CTL-EN cells with GM-CSF receptors.
We generated retroviral-IRES constructs that allow co-expression of both α and β subunits of the GM-CSF receptor (GMR) receptor. 32 Importantly, primary cells allow multiple biological readouts to be examined including cell survival, proliferation and colony formation. 29 Wild type (wtβ c ) and Tyr577Phe mutant receptors were expressed at equivalent levels.
Transduction Figure 1A , the number of colonies observed in cells expressing the Tyr577Phe mutant was significantly higher (p<0.01) than that in cells expressing the wtβ c . We also compared colony growth with mutants in which either all 8 of the tyrosine residues were mutated to phenylalanine (F8) or the serine at position 585 was replaced with a glycine residue (Ser585Gly) ( Figure 1A ). There was no significant difference in the colony numbers from the Ser585Gly mutant when compared to wtβ c (p>0.05). In contrast, the F8 mutant, in which no tyrosine residues remain, showed essentially no colony formation in response to GM-CSF. With each receptor mutant we observed no colony growth in the absence of cytokine and similar levels of colony formation were observed in the presence of a cocktail of IL-6, SCF To observe the morphology of cultured FL cells, we transferred colonies from the assays shown in Figure 1 to slides and stained with haematoxylin. Additionally we cultured wtβ c or Tyr577Phe expressing FL cells in 100ng/mL GM-CSF or the cytokine cocktail as outlined above. Cells from these cultures were either stained with lineagespecific antibodies or were cytospun and stained with haematoxylin. All of these approaches indicated that after 14 days in culture in GM-CSF >90% cells expressing either wtβ c or Tyr577Phe mutant receptor were identified as monocyte or macrophage (data not shown). Thus the increased colony formation observed for the Tyr577Phe mutant in Figure 1 was not due to altered differentiation of cells in response to GM-CSF. As colony formation relies on the ability of GM-CSF to coordinately regulate cell survival and proliferation we investigated whether the increased colony formation observed in FL cells expressing the Tyr577Phe mutant was due to increased cell Previous studies by Gu et al. 10 suggested that Tyr577 is the major site required for Gab2 phosphorylation in response to GM-CSF. However, our results in FL cells
showed that mutation of Tyr577 resulted both in increased basal Gab2 phosphorylation and also in response to GM-CSF stimulation ( Figure 3A ). This was not simply due to higher expression of the Tyr577Phe mutant compared to the wtβ c in FL cells as these were expressed at similar levels in 12 independent transductions both 
Tyr577Phe
β c in response to GM-CSF. CTL-EN cells were stimulated with GM-CSF, β c was immunoprecipitated and the immunoprecipitates were subjected to an in vitro PI(3,4,5)P 3 5-phosphatase assay. We found that whilst the wtβ c was able to recruit 5'-phosphatase activity, no such recruitment was observed for the Tyr577Phe mutant ( Figure 5) . Quantitation of the data in Figure 5B is shown in Figure 5C . These have been demonstrated in patients with severe congenital neutropenia (SCN). 39 Our findings that the Tyr577Phe mutant promoted enhanced GM-CSF-mediated cell proliferation and survival in primary cells was somewhat surprising as previous experiments examining the biological effects of mutating Tyr577 had not detected any significant perturbation in GM-CSF or IL-3 activities. Shc has been shown to be recruited to a broad spectrum of cell surface receptors and has been widely proposed to be a key regulator of Ras/MAPK signaling. 43 The PTB domain of Shc has been shown to bind phosphotyrosine residues within NXXY motifs (where Y is a phosphotyrosine) and this represents a key mechanism by which Shc is recruited to a range of cell surface receptors including IL-2Rβ (Figure 3) underscoring the functionally redundant roles served by Tyr577, Tyr612 and Tyr695 in regulating Ras/MAPK signaling.
In contrast to Ras/MAPK signalling, our results show that Tyr577 of β c serves unique and non-redundant functions in terms of PI3K signaling. The recruitment of PI3K activity to the Tyr577Phe mutant receptor was not only increased, but also the kinetics of PI3K activation were sustained compared to wtβ c (Figure 4) . Whilst mutating Tyr577 de-represses a PI3K binding site on the β c subunit facilitating enhanced PI3K signaling none of the remaining 5 β c tyrosines lie within a suitable context for binding the SH2 domains of p85. Rather, our results support the notion that Ser585 phosphorylation of β c is de-repressed in the context of the Tyr577Phe mutant and recruits PI3K. Our previous studies have shown that Ser585 provides an important docking site for the 14-3-3 family of scaffold proteins and is important for the recruitment of PI3K to the receptor. 8 We have also shown that the phosphorylation of Tyr577 sterically interferes with the phosphorylation of Ser585 with the phosphorylation of Ser585 and of Tyr577 being mutually exclusive. 29 The results presented herein suggest that the block in Ser585 phosphorylation normally exerted by the phosphorylation of Tyr577 is lost in the Tyr577Phe mutant leading to the deregulation of Ser585 phosphorylation and enhanced PI3K signaling. In line with these results, we have also shown that pharmacological blockade of Tyr577 phosphorylation using a JAK2 inhibitor also leads to constitutive Ser585 phosphorylation (data not shown).
Our results showing that Gab2 tyrosine phosphorylation and PI3K signalling were enhanced in the Tyr577Phe mutant were unexpected as Gu et al. have shown that mutation of Tyr577 results in decreased Gab2 tyrosine phosphorylation in response to GM-CSF. 10 Nevertheless, our findings do highlight the correlation between enhanced biological activity, Gab2 phosphorylation and PI3K activity and are consistent with a major role of PI3K in GM-CSF function. 8;9 Gab2 is the major phosphorylated binding protein for p85 of PI3K responsible for >50% of cytokine-mediated PI3K activity. 10 It remains to be seen, however, how Gab2 is recruited to the Tyr577Phe mutant, particularly since Shc phosphorylation appears to be a prerequisite itself for Gab2
For personal use only. on November 12, 2017. by guest www.bloodjournal.org From phosphorylation. 10 One possibility is that Gab2 is recruited through binding to SHP- While 3'-inositol phosphatases such as PTEN are thought to control basal levels of PIP(3,4) and PIP (3, 4, 5) in the plasma membrane, the 5'-inositol phosphatases such as SHIP are proposed to negatively regulate growth factor-and cytokine-induced production of PIP(4,5) and PIP (3, 4, 5) . 57 This concept is supported by the observation that hematopoietic cells derived from SHIP -/-mice have increased and sustained PI3K signaling in response to cytokines. 20 Thus, it is interesting to note that two key features of the Tyr577Phe mutant β c have also been reported for primary hematopoietic cells derived from SHIP -/-mice. Firstly, IL-3 promoted enhanced PI3K
signaling in SHIP -/-hematopoietic cells and, secondly, these cells were hypersensitive to IL-3 and GM-CSF. 19;20 In fact, there is considerable overlap in the phenotypes displayed by SHIP -/-mice and mice over-expressing GM-CSF including a myeloproliferative-like phenotype accompanied by infiltration of peripheral tissues by myeloid cells 19;20;58 . In a similar manner to the Tyr577Phe mutant described in our 
